"Neurological Associates of Santa Monica servicing the Los Angeles area, has been providing neurological health care for decades to both the local community and to people from around the world. The practice has successfully blended personalized clinical care along with education and clinical research. "The best neurologist in Los Angeles" Each neurologist at the practice has been nationally and internationally recognized by peer and consumer groups, have written numerous publications. Two of Dr. Jordan's publications include: How to Test a Presidential Candidate for Dementia and Covid-19 Pandemic May Prevent Alzheimers's Disease."

During the past decade, Neurological Associates of West Los Angeles conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurological Associates of West Los Angeles" #1 collaborator was "BioRich Medical" with 1 trials as a collaborator, "BioVie Inc." with 1 trials as a collaborator, "Cell Surgical Network Inc." with 1 trials as a collaborator, "EmCyte Corporation" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Neurological Associates of West Los Angeles" are "Alzheimer Disease" (3 trials), "Anxiety Disorders" (2 trials), "Depression" (2 trials), "Mild Cognitive Impairment" (2 trials) and "Neuralgia" (2 trials). Many other conditions were trialed in "Neurological Associates of West Los Angeles" in a lesser frequency.

Most popular intervention types in "Neurological Associates of West Los Angeles" are "Device" (11 trials), "Other" (6 trials), "Drug" (4 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Focused Ultrasound" (5 trials), "Exosomes" (2 trials), "Focused Transcranial Ultrasound" (2 trials), "Transcranial Magnetic Stimulation" (2 trials) and "A2M enriched plasma" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurological Associates of West Los Angeles" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Neurological Associates of West Los Angeles". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 12 are Enrolling by invitation. In total, there were 3 completed trials in Neurological Associates of West Los Angeles, 4 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neurological Associates of West Los Angeles, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".